150 related articles for article (PubMed ID: 28585036)
1. Differential expression pattern of protein markers for predicting chemosensitivity of dexamethasone-based chemotherapy of B cell acute lymphoblastic leukemia.
Dehghan-Nayeri N; Eshghi P; Pour KG; Rezaei-Tavirani M; Omrani MD; Gharehbaghian A
Cancer Chemother Pharmacol; 2017 Jul; 80(1):177-185. PubMed ID: 28585036
[TBL] [Abstract][Full Text] [Related]
2. Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.
Tesfai Y; Ford J; Carter KW; Firth MJ; O'Leary RA; Gottardo NG; Cole C; Kees UR
Leuk Res; 2012 Mar; 36(3):299-306. PubMed ID: 21889797
[TBL] [Abstract][Full Text] [Related]
3. Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B-precursor acute lymphoblastic leukemia.
Morishita N; Tsukahara H; Chayama K; Ishida T; Washio K; Miyamura T; Yamashita N; Oda M; Morishima T
Pediatr Blood Cancer; 2012 Jul; 59(1):83-9. PubMed ID: 22183914
[TBL] [Abstract][Full Text] [Related]
4. Targeting FoxM1 transcription factor in T-cell acute lymphoblastic leukemia cell line.
Tüfekçi Ö; Yandım MK; Ören H; İrken G; Baran Y
Leuk Res; 2015 Mar; 39(3):342-7. PubMed ID: 25557384
[TBL] [Abstract][Full Text] [Related]
5. High RASD1 transcript levels at diagnosis predicted poor survival in adult B-cell acute lymphoblastic leukemia patients.
Wang S; Wang C; Wang W; Hao Q; Liu Y
Leuk Res; 2019 May; 80():26-32. PubMed ID: 30925311
[TBL] [Abstract][Full Text] [Related]
6. Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.
Karawajew L; Dworzak M; Ratei R; Rhein P; Gaipa G; Buldini B; Basso G; Hrusak O; Ludwig WD; Henze G; Seeger K; von Stackelberg A; Mejstrikova E; Eckert C
Haematologica; 2015 Jul; 100(7):935-44. PubMed ID: 26001791
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
Ghodousi ES; Aberuyi N; Rahgozar S
Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
[TBL] [Abstract][Full Text] [Related]
8. MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents.
Suzuki K; Okuno Y; Kawashima N; Muramatsu H; Okuno T; Wang X; Kataoka S; Sekiya Y; Hamada M; Murakami N; Kojima D; Narita K; Narita A; Sakaguchi H; Sakaguchi K; Yoshida N; Nishio N; Hama A; Takahashi Y; Kudo K; Kato K; Kojima S
J Clin Oncol; 2016 Oct; 34(28):3451-9. PubMed ID: 27507882
[TBL] [Abstract][Full Text] [Related]
9. Cysteine and glycine-rich protein 2 (CSRP2) transcript levels correlate with leukemia relapse and leukemia-free survival in adults with B-cell acute lymphoblastic leukemia and normal cytogenetics.
Wang SJ; Wang PZ; Gale RP; Qin YZ; Liu YR; Lai YY; Jiang H; Jiang Q; Zhang XH; Jiang B; Xu LP; Huang XJ; Liu KY; Ruan GR
Oncotarget; 2017 May; 8(22):35984-36000. PubMed ID: 28415593
[TBL] [Abstract][Full Text] [Related]
10. Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia.
Vilas-Zornoza A; Agirre X; Abizanda G; Moreno C; Segura V; De Martino Rodriguez A; José-Eneriz ES; Miranda E; Martín-Subero JI; Garate L; Blanco-Prieto MJ; García de Jalón JA; Rio P; Rifón J; Cigudosa JC; Martinez-Climent JA; Román-Gómez J; Calasanz MJ; Ribera JM; Prósper F
Leukemia; 2012 Jul; 26(7):1517-26. PubMed ID: 22307227
[TBL] [Abstract][Full Text] [Related]
11. BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia.
Jiang N; Koh GS; Lim JY; Kham SK; Ariffin H; Chew FT; Yeoh AE
Exp Hematol; 2011 Mar; 39(3):321-9, 329.e1-3. PubMed ID: 21130142
[TBL] [Abstract][Full Text] [Related]
12. Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance.
Han SS; Han S; Kamberos NL
Biochem Biophys Res Commun; 2014 Sep; 452(3):669-75. PubMed ID: 25193702
[TBL] [Abstract][Full Text] [Related]
13. Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.
Efferth T; Sauerbrey A; Steinbach D; Gebhart E; Drexler HG; Miyachi H; Chitambar CR; Becker CM; Zintl F; Humeny A
Int J Oncol; 2003 Aug; 23(2):509-17. PubMed ID: 12851703
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone-resistant human Pre-B leukemia 697 cell line evolving elevation of intracellular glutathione level: an additional resistance mechanism.
Inoue H; Takemura H; Kawai Y; Yoshida A; Ueda T; Miyashita T
Jpn J Cancer Res; 2002 May; 93(5):582-90. PubMed ID: 12036455
[TBL] [Abstract][Full Text] [Related]
15. Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia.
Spenerova M; Dzubak P; Srovnal J; Radova L; Burianova R; Konecny P; Salkova S; Novak Z; Pospisilova D; Stary J; Blazek B; Hak J; Votava T; Timr P; Kaiserova E; Bubanska E; Mihal V; Hajduch M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):422-7. PubMed ID: 23128824
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.
Veltroni M; De Zen L; Sanzari MC; Maglia O; Dworzak MN; Ratei R; Biondi A; Basso G; Gaipa G;
Haematologica; 2003 Nov; 88(11):1245-52. PubMed ID: 14607753
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of SORCIN is a Prognostic Biomarker for Multidrug-Resistant Pediatric Acute Lymphoblastic Leukemia and Correlates with Upregulated MDR1/P-gp.
Dabaghi M; Rahgozar S; Moshtaghian J; Moafi A; Abedi M; Pourabutaleb E
Genet Test Mol Biomarkers; 2016 Sep; 20(9):516-21. PubMed ID: 27382961
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential predictive markers of dexamethasone resistance in childhood acute lymphoblastic leukemia.
Dehghan-Nayeri N; Rezaei-Tavirani M; Omrani MD; Gharehbaghian A; Goudarzi Pour K; Eshghi P
J Cell Commun Signal; 2017 Jun; 11(2):137-145. PubMed ID: 27778231
[TBL] [Abstract][Full Text] [Related]
19. A childhood acute lymphoblastic leukemia-specific lncRNA implicated in prednisolone resistance, cell proliferation, and migration.
Ouimet M; Drouin S; Lajoie M; Caron M; St-Onge P; Gioia R; Richer C; Sinnett D
Oncotarget; 2017 Jan; 8(5):7477-7488. PubMed ID: 27980230
[TBL] [Abstract][Full Text] [Related]
20. [Identification of new markers for childhood acute lymphoblastic leukemia by MALDI-TOF-MS].
Wang D; Lu YQ; Liu YF; Su SF; Li B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1365-9. PubMed ID: 23257434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]